US court denies Teva's motion on Pulmicort generic
This article was originally published in Scrip
Executive Summary
A US judge has deniedTeva Pharmaceutical Industries' motion for summary judgement of non-infringement of two Orange Book-listed patents protectingAstraZeneca's inhaled corticosteroid Pulmicort Respules (budesonide inhalation suspension).